EchoMRI™ is an international research instruments company that develops, manufactures and markets NMR and CT-based whole body composition and tissue characterization equipment. Their body composition analyzers are used worldwide to measure body composition responses to drugs, genetic knockouts, diet, and ageing, in research areas such as obesity, diabetes, nutrition, pharmacology, osteoporosis, cardiology, animal physiology, etc. Beyond the existing applications, new extensions of the technology are being researched.
Several hundred EchoMRI™ systems have been successfully installed in more than 80 pharmaceutical companies and more than 150 universities, medical facilities, hospitals and other leading metabolic research institutions in the US, Canada, Europe, and Asia for metabolic and obesity research in live animals. Many of their customers have multiple EchoMRI™ units.
As medical development progresses from animal studies to human trials, there has been growing demand to apply EchoMRI™ technology in clinical trials for humans. In response, EchoMRI™ has developed body composition analyzers for infants, children, and grown humans, aimed at providing solutions to the pharmaceutical and medical industries for testing the efficacy in clinical trials of anti-obesity and metabolic drugs and treatments.
EchoMRI™ has R&D and manufacturing offices in Singapore and Houston, USA.